Table 2.
Embryonic outcome between the two groups.
| ICSI |
IVF |
ICSI vs. IVF |
|
|---|---|---|---|
| n = 158 (47%) | n = 178 (53%) | p-Value | |
| Oocytes per group (n) | 11.28 ± 5.61 | 10.16 ± 4.83 | 0.051 |
| MII per group (n) | 8.24 ± 5.07 | 8.72 ± 4.51 | 0.355 |
| 2PN/oocytes (%) | 69.12 (900/1302) | 71.73 (1114/1553) | 0.138 |
| Utilized embryos per group (n) | 2.18 ± 2.05 | 2.22 ± 2.17 | 0.837 |
| High-quality embryos per group (n) | 0.32 ± 0.67 | 0.16 ± 0.62 | 0.001* |
| Utilized embryos/oocytes (%) | 26.42 (344/1302) | 25.50 (396/1553) | 0.578 |
| Utilized embryos/2 PN (%) | 38.22 (344/900) | 35.55 (396/1114) | 0.227 |
| High-quality embryos/2 PN (%) | 5.56 (50/900) | 2.60 (29/1114) | 0.001* |
| Cancel cycles/ART cycle (%) | 25.32 (40/158) | 26.40 (47/178) | 0.901 |
Two-sample independent t-test or Person χ2 test.
*Significant difference between IVF and ICSI groups, P < 0.05.